China Universal Asset Management Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
18,000
+2,000
+13% +$179K 0.11% 139
2026
Q1
$1.15M Hold
16,000
0.09% 173
2025
Q4
$1.27M Sell
16,000
-7,300
-31% -$575K 0.1% 162
2025
Q3
$1.76M Sell
23,300
-6,700
-22% -$459K 0.15% 125
2025
Q2
$2.07M Sell
30,000
-7,871
-21% -$516K 0.19% 107
2025
Q1
$2.57M Buy
+37,871
New +$2.27M 0.24% 89
2023
Q2
Sell
-1,115
Closed -$82.9K 454
2023
Q1
$82.9K Hold
1,115
0.03% 133
2022
Q4
$104K Sell
1,115
-32,095
-97% -$3.1M 0.04% 121
2022
Q3
$3.17M Buy
33,210
+28,716
+639% +$2.84M 1.33% 27
2022
Q2
$416K Sell
4,494
-24,307
-84% -$2.37M 0.17% 68
2022
Q1
$2.92M Buy
+28,801
New +$3.03M 1.03% 39

Other funds holding CVS

China Universal Asset Management Company's CVS Position: Q2 2026 in Review

China Universal Asset Management Company increased its CVS Health (CVS) stake by 13% in Q2 2026, buying an estimated $179K and bringing the position to 18,000 shares worth $1.86M. The position accounts for 0.11% of the portfolio, ranked #139.

China Universal Asset Management Company first reported a position in CVS in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.17M in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • China Universal Asset Management Company held 18,000 shares of CVS Health worth $1.86M as of Q2 2026.
  • China Universal Asset Management Company bought 2,000 CVS Health shares in Q2 2026, an estimated $179K.
  • CVS Health made up 0.11% of China Universal Asset Management Company's portfolio in Q2 2026, its #139 holding.
  • China Universal Asset Management Company first reported a position in CVS Health in Q1 2022 and has held it in 11 quarters since.
  • China Universal Asset Management Company's CVS Health position peaked at $3.17M in Q3 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.